7 Feb 2020
The number of cases of hospitalized patients with 2019 novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) increased rapidly with no apparent reason.
This study aimed to collect and analyse and epidemiological, demographic, clinical, laboratory, radiological, and treatment data and find out whether the transmission was happening in the hospital and if it would be possible to track.
Also By
ISARIC
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
- An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a rando
Please Sign in (or Register) to view further.